Crossmark

Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates

Crossref DOI link: https://doi.org/10.1007/s11682-018-9891-3

Published Online: 2018-05-10

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matías-Guiu, Jordi A. https://orcid.org/0000-0001-5520-2708
Cabrera-Martín, María Nieves

Valles-Salgado, María

Rognoni, Teresa

Galán, Lucía

Moreno-Ramos, Teresa

Carreras, José Luis

Matías-Guiu, Jorge
License Information

Text and Data Mining valid from 2018-05-10
More Information

Article History

First Online: 10 May 2018

Compliance with ethical standards

:

: The authors declare than they have no conflict of interest.

: All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below